19. NIALL FILEWOD
Information acquired: 2025
NIALL FILEWOD is an academic who published a paper in 2022 entitled Phenobarbital for the management of severe acute alcohol withdrawal (the PHENOMANAL trial): a pilot. NIALL FILEWOD published this work as part of a team: Filewod, Niall. Here is a description of this work: Bac,,ground Benzodiazepines are considered first-line treatment for patients experiencing severe acute alcohol withdrawal syndrome (sAAWS). Although several medications have been evaluated as potential adjuvant treatments for sAAWS, barbiturates show particular promise. Objective In the PHENOMANAL trial, we will assess the feasibility of conducting an allocation-concealed, quadruple-blinded, randomized controlled trial (RCT) comparing symptom-triggered benzodiazepine therapy with either a single dose of adjuvant intravenous (IV) phenobarbital (7. 5 mg/kg of ideal body weight) or a single dose of matching IV placebo for patients with sAAWS. Methods We will recruit adult patients from the Emergency Department, Intensive Care Unit, or hospital wards with a Clinical Institute of Withdrawal â€" Adult revised (CIWA-Ar) score of 16 or more after.